Miwon Specialty Chemical Co., Ltd. (KRX:268280)
South Korea · Delayed Price · Currency is KRW 141,300
-800 (-0.56%)
At close: Feb 11, 2026
Miwon Specialty Chemical Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 532,413 | 509,267 | 437,673 | 611,650 | 531,343 | 371,990 |
Other Revenue | -0 | - | -0 | -0 | - | -0 |
| 532,413 | 509,267 | 437,673 | 611,650 | 531,343 | 371,990 | |
Revenue Growth (YoY) | 9.93% | 16.36% | -28.44% | 15.11% | 42.84% | -1.55% |
Cost of Revenue | 418,636 | 406,471 | 383,706 | 480,003 | 395,584 | 296,171 |
Gross Profit | 113,777 | 102,796 | 53,967 | 131,647 | 135,759 | 75,819 |
Selling, General & Admin | 38,116 | 37,752 | 26,296 | 44,574 | 34,511 | 20,893 |
Research & Development | 5,722 | 4,850 | 4,439 | 4,638 | 4,629 | 4,356 |
Amortization of Goodwill & Intangibles | 1.17 | 1.6 | 68 | 228.8 | 228.83 | 228.61 |
Other Operating Expenses | 228.7 | 242.47 | 211.44 | 220.25 | 198.71 | 363.83 |
Operating Expenses | 45,200 | 44,029 | 31,440 | 50,793 | 40,727 | 26,611 |
Operating Income | 68,577 | 58,767 | 22,527 | 80,853 | 95,032 | 49,208 |
Interest Expense | -1,971 | -2,141 | -2,234 | -1,142 | -60.83 | -179.95 |
Interest & Investment Income | 3,861 | 4,171 | 2,372 | 929.68 | 468.7 | 419.41 |
Currency Exchange Gain (Loss) | 6,426 | 10,260 | 3,533 | 3,329 | 9,176 | -3,976 |
Other Non Operating Income (Expenses) | 1,499 | 451.09 | 639.18 | 671.35 | 878.7 | 295.88 |
EBT Excluding Unusual Items | 78,393 | 71,508 | 26,837 | 84,642 | 105,494 | 45,768 |
Gain (Loss) on Sale of Investments | - | - | -12.1 | - | - | - |
Gain (Loss) on Sale of Assets | 1,223 | 461.86 | 187.66 | 254.66 | 4.29 | 97.45 |
Asset Writedown | - | - | - | - | - | -70.13 |
Pretax Income | 79,616 | 71,970 | 27,013 | 84,896 | 105,499 | 45,795 |
Income Tax Expense | 19,909 | 17,403 | 8,408 | 20,072 | 25,595 | 11,129 |
Net Income | 59,708 | 54,567 | 18,605 | 64,824 | 79,903 | 34,666 |
Net Income to Common | 59,708 | 54,567 | 18,605 | 64,824 | 79,903 | 34,666 |
Net Income Growth | 33.56% | 193.30% | -71.30% | -18.87% | 130.50% | -12.38% |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change (YoY) | -0.66% | -1.26% | -1.24% | -0.27% | -1.86% | -2.15% |
EPS (Basic) | 12300.55 | 11163.61 | 3758.22 | 12932.24 | 15897.28 | 6768.94 |
EPS (Diluted) | 12300.55 | 11163.61 | 3758.00 | 12932.00 | 15897.00 | 6768.94 |
EPS Growth | 34.45% | 197.06% | -70.94% | -18.65% | 134.85% | -10.45% |
Free Cash Flow | 40,041 | 34,261 | 84,176 | -11,155 | -13,161 | 49,828 |
Free Cash Flow Per Share | 8248.86 | 7009.32 | 17003.96 | -2225.48 | -2618.39 | 9729.70 |
Dividend Per Share | 2500.000 | 2500.000 | - | - | - | - |
Gross Margin | 21.37% | 20.18% | 12.33% | 21.52% | 25.55% | 20.38% |
Operating Margin | 12.88% | 11.54% | 5.15% | 13.22% | 17.89% | 13.23% |
Profit Margin | 11.21% | 10.71% | 4.25% | 10.60% | 15.04% | 9.32% |
Free Cash Flow Margin | 7.52% | 6.73% | 19.23% | -1.82% | -2.48% | 13.40% |
EBITDA | 95,197 | 85,421 | 50,742 | 101,140 | 111,784 | 65,716 |
EBITDA Margin | 17.88% | 16.77% | 11.59% | 16.54% | 21.04% | 17.67% |
D&A For EBITDA | 26,620 | 26,653 | 28,214 | 20,287 | 16,752 | 16,507 |
EBIT | 68,577 | 58,767 | 22,527 | 80,853 | 95,032 | 49,208 |
EBIT Margin | 12.88% | 11.54% | 5.15% | 13.22% | 17.89% | 13.23% |
Effective Tax Rate | 25.01% | 24.18% | 31.13% | 23.64% | 24.26% | 24.30% |
Advertising Expenses | - | 6.11 | 23.72 | 23.99 | 15.53 | 11.71 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.